|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=5771; geneSymbol=PTPN2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.248458305; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242909916; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=306; geneSymbol=ANXA3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=10678; geneSymbol=B3GNT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123181358; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.167568474; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=9308; geneSymbol=CD83; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123267234; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=122618; geneSymbol=PLD4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.129424521; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=25674272; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=TNFAIP3 rs2230926 polymorphisms in rheumatoid arthritis of southern Chinese Han population: a case-control study.; score=0.167568474; Year=2014; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=116985; geneSymbol=ARAP1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.000271442; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2230926 |
SNP |
PedAM |
snpId=rs2230926; pubmedId=23577190; geneId=9034; geneSymbol=CCRL2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.005710211; Year=2013; geneSymbol_dbSNP=TNFAIP3; CHROMOSOME=6; POS=137874929; REF=T; ALT=C,G |
details
|
|
|
rs2233407 |
SNP |
PedAM |
snpId=rs2233407; pubmedId=20448286; geneId=4792; geneSymbol=NFKBIA; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Several SNPs mapping to the TLR and NFkappaB signalling systems demonstrated association with anti-TNF response as a whole and, in particular, with response to etanercept. Validation of these findings in an independent cohort is now warranted.]; score=0.013006804; Year=2010; geneSymbol_dbSNP=NFKBIA; CHROMOSOME=14; POS=35405317; REF=T; ALT=A |
details
|
|
|
rs2233424 |
SNP |
PedAM |
snpId=rs2233424; pubmedId=24390342; geneId=4794; geneSymbol=NFKBIE; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Genetics of rheumatoid arthritis contributes to biology and drug discovery.; score=0.245005506; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44266184; REF=C; ALT=T |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=5771; geneSymbol=PTPN2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.248458305; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=10678; geneSymbol=B3GNT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123181358; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=9308; geneSymbol=CD83; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123267234; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=122618; geneSymbol=PLD4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23577190; geneId=9034; geneSymbol=CCRL2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.005710211; Year=2013; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=22446963; geneId=4794; geneSymbol=NFKBIE; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Our study identified nine loci newly associated with rheumatoid arthritis at a threshold of P < 5.0 A 10(-8), including B3GNT2, ANXA3, CSF2, CD83, NFKBIE, ARID5B, PDE2A-ARAP1, PLD4 and PTPN2.]; score=0.245005506; Year=2012; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
|
rs2233434 |
SNP |
PedAM |
snpId=rs2233434; pubmedId=23028356; geneId=4794; geneSymbol=NFKBIE; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Functional variants in NFKBIE and RTKN2 involved in activation of the NF-¦ÊB pathway are associated with rheumatoid arthritis in Japanese.; score=0.245005506; Year=2012; geneSymbol_dbSNP=NFKBIE; CHROMOSOME=6; POS=44265183; REF=A; ALT=G |
details
|
|
